Copaxone (MS drug)
Who
Michael Sela, Ruth Arnon and Dvora Teitelbaum, Israeli scientists at the Weizmann Institute; marketed by Israel's Teva.
When
1960s–1970s (approved 1996)
Where
Weizmann Institute, Rehovot, Israel
Copaxone (glatiramer acetate) is a widely used drug that reduces relapses in multiple sclerosis. It was developed at Israel's Weizmann Institute of Science by Michael Sela, Ruth Arnon and Dvora Teitelbaum, and later brought to market by the Israeli company Teva. Its Israeli-Jewish inventors turned laboratory research into a therapy used by patients around the world.
Part of “The Gifts of the Jews” — verified Jewish contributions to the world, with sources.